Therapeutic Scope of Panchakarma in Childhood Disorders: A Comprehensive Review

Abstract

Kaumarbhritya, one of the eight primary branches of Ayurveda, encompasses comprehensive management of pediatric disorders, with Panchakarma offering significant therapeutic potential in various childhood conditions despite misconceptions regarding its pediatric applicability. This review systematically examines the classical foundations, clinical applications, and evidence-based scope of Panchakarma procedures in managing pediatric disorders. A comprehensive literature search was conducted in PubMed, DHARA Online, AYUSH Research Portal, and Google Scholar (2000-2024), along with classical Ayurvedic texts (Charaka Samhita, Sushruta Samhita, Kashyapa Samhita). Studies reporting clinical outcomes of Panchakarma interventions in children (0-18 years) were included. The review identified 47 relevant publications including 3 clinical trials, 12 case series, 8 case reports, and 24 conceptual reviews. Evidence demonstrates successful applications in cerebral palsy (4 studies, n=127 children showing 19-21% improvement in motor functions), neurodevelopmental disorders (cognitive enhancement in 3 studies), muscular dystrophies (quality of life improvement in 2 studies), and respiratory conditions. Key procedures include Matra Basti (8-15 days), Nasya (7-30 days), and modified Vamana-Virechana protocols with age-specific modifications, dose calculations (one-fourth to one-half of adult dose), and established safety protocols. Panchakarma offers significant therapeutic potential in pediatric disorders when applied with proper understanding of classical principles and appropriate modifications, with evidence supporting its application in cerebral palsy, neurodevelopmental disorders, and respiratory conditions. Further large-scale randomized controlled trials with standardized protocols are warranted.